Literature DB >> 21603078

An insult-inducible vector system activated by hypoxia and oxidative stress for neuronal gene therapy.

Michelle Y Cheng1, I-Ping Lee, Michael Jin, Guohua Sun, Heng Zhao, Gary K Steinberg, Robert M Sapolsky.   

Abstract

Gene therapy has demonstrated the protective potential of a variety of genes against stroke. However, conventional gene therapy vectors are limited due to the inability to temporally control their expression, which can sometimes lead to deleterious side effects. Thus, an inducible vector that can be temporally controlled and activated by the insult itself would be advantageous. Using hypoxia responsive elements (HRE) and antioxidant responsive elements (ARE), we have constructed an insult-inducible vector activated by hypoxia and reactive oxygen species (ROS). In COS7 cells, the inducible ARE-HRE-luciferase vectors are highly activated by oxygen deprivation, hydrogen peroxide treatment, and the ROS-induced transcription factor NF-E2-related factor 2 (Nrf2). Using a defective herpes virus, the neuroprotective potential of this inducible vector was tested by over-expressing the transcription factor Nrf2. In primary cortical cultures, expression of the inducible ARE-HRE-Nrf2 protects against oxygen glucose deprivation, similar to that afforded by the constitutively expressed Nrf2. This ARE+HRE vector system is advantageous in that it allows the expression of a transgene to be activated not only during hypoxia but also maintained after reperfusion, thus prolonging the transgene expression during an ischemic insult. This insult-inducible vector system will be a valuable gene therapy tool for activating therapeutic/protective genes in cerebrovascular diseases.

Entities:  

Year:  2011        PMID: 21603078      PMCID: PMC3097421          DOI: 10.1007/s12975-010-0060-2

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  44 in total

Review 1.  Gene therapy using viral vectors for acute neurologic insults.

Authors:  R M Sapolsky; G K Steinberg
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

2.  Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain.

Authors:  M Bergeron; A Y Yu; K E Solway; G L Semenza; F R Sharp
Journal:  Eur J Neurosci       Date:  1999-12       Impact factor: 3.386

3.  Adeno-associated viral-vector-mediated hypoxia-inducible vascular endothelial growth factor gene expression attenuates ischemic brain injury after focal cerebral ischemia in mice.

Authors:  Fanxia Shen; Hua Su; Yongfeng Fan; Yongmei Chen; Yiqian Zhu; Weizhong Liu; William L Young; Guo-Yuan Yang
Journal:  Stroke       Date:  2006-08-31       Impact factor: 7.914

4.  Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample.

Authors:  Richard Dubinsky; Sue-Min Lai
Journal:  Neurology       Date:  2006-06-13       Impact factor: 9.910

5.  A computational model of intracellular oxygen sensing by hypoxia-inducible factor HIF1 alpha.

Authors:  Amina A Qutub; Aleksander S Popel
Journal:  J Cell Sci       Date:  2006-08-15       Impact factor: 5.285

6.  Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury.

Authors:  Martin O Leonard; Niamh E Kieran; Katherine Howell; Melissa J Burne; Raghu Varadarajan; Saravanakumar Dhakshinamoorthy; Alan G Porter; Cliona O'Farrelly; Hamid Rabb; Cormac T Taylor
Journal:  FASEB J       Date:  2006-12       Impact factor: 5.191

7.  Oxidative stress-inducible lentiviral vectors for gene therapy.

Authors:  H Hurttila; J K Koponen; E Kansanen; H-K Jyrkkänen; A Kivelä; R Kylätie; S Ylä-Herttuala; A-L Levonen
Journal:  Gene Ther       Date:  2008-05-01       Impact factor: 5.250

8.  Dopamine activates Nrf2-regulated neuroprotective pathways in astrocytes and meningeal cells.

Authors:  Andy Y Shih; Heidi Erb; Timothy H Murphy
Journal:  J Neurochem       Date:  2007-01-12       Impact factor: 5.372

9.  Nrf2 activators provide neuroprotection against 6-hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures.

Authors:  Aubrey Siebert; Vandan Desai; Krish Chandrasekaran; Gary Fiskum; M Samir Jafri
Journal:  J Neurosci Res       Date:  2009-05-15       Impact factor: 4.164

10.  Role of reactive oxygen species in modulation of Nrf2 following ischemic reperfusion injury.

Authors:  Z A Shah; R-C Li; R K Thimmulappa; T W Kensler; M Yamamoto; S Biswal; S Doré
Journal:  Neuroscience       Date:  2007-05-15       Impact factor: 3.590

View more
  2 in total

Review 1.  ROS and brain diseases: the good, the bad, and the ugly.

Authors:  Aurel Popa-Wagner; Smaranda Mitran; Senthilkumar Sivanesan; Edwin Chang; Ana-Maria Buga
Journal:  Oxid Med Cell Longev       Date:  2013-12-05       Impact factor: 6.543

Review 2.  Intracerebral Hemorrhage, Oxidative Stress, and Antioxidant Therapy.

Authors:  Xiaochun Duan; Zunjia Wen; Haitao Shen; Meifen Shen; Gang Chen
Journal:  Oxid Med Cell Longev       Date:  2016-04-14       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.